Methods and compositions employing a novel stearoyl-coa desaturase-hscd5
CA 2430987 A1 · Owner: Xenon Genetics, Inc. · Inventors: Brownlie, Alison J.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A cDNA encoding a novel human stearoy-CoA desaturase (dubbed "hSCD5") as well as vectors and cells comprising such polynucleotide are disclosed. Also described are assay methods for determining the ability of small molecules and other chemical agents to increase or decrease he enzymatic activity and/or gene expression level of hSCD5 as well as processes for using such agents to treat, prevent or diagnose a variety of diseases and other conditions.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 26, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 26, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 26, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.